Neutrophil activation precedes myocardial injury in patients with acute myocardial infarction
Standard
Neutrophil activation precedes myocardial injury in patients with acute myocardial infarction. / Goldmann, Britta U; Rudolph, Volker; Rudolph, Tanja K; Holle, Ann-Katrin; Hillebrandt, Matthias; Meinertz, Thomas; Baldus, Stephan.
in: FREE RADICAL BIO MED, Jahrgang 47, Nr. 1, 01.07.2009, S. 79-83.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Neutrophil activation precedes myocardial injury in patients with acute myocardial infarction
AU - Goldmann, Britta U
AU - Rudolph, Volker
AU - Rudolph, Tanja K
AU - Holle, Ann-Katrin
AU - Hillebrandt, Matthias
AU - Meinertz, Thomas
AU - Baldus, Stephan
PY - 2009/7/1
Y1 - 2009/7/1
N2 - Myeloperoxidase (MPO), a heme protein abundantly expressed and secreted by polymorphonuclear neutrophils (PMN), has emerged as a critical mediator in coronary atherosclerosis. Retrospective analyses have suggested that free plasma levels of MPO predict adverse outcome in patients with low troponin T (TnT) levels who subsequently experience myocardial injury. The aim of this study was to evaluate the time course of MPO plasma levels in the early stages of acute myocardial infarction (AMI). Of 155 consecutive patients hospitalized for acute coronary syndromes, 38 presenting within 2 h of the onset of symptoms and subsequently diagnosed for AMI were included in the study. Serial blood samples taken between 1 and 24 h after the onset of chest pain were analyzed for MPO, TnT, creatine kinase MB, myoglobin, and high sensitive C-reactive protein. Fifty patients with angiographically proven but stable coronary artery disease (CAD) served as controls. In contrast to all other investigated markers, MPO was markedly elevated within 2 h of symptom onset in patients with AMI. Heparin, which is known to increase MPO plasma levels in patients with stable CAD, had no effect on MPO plasma levels in AMI patients. High levels of MPO plasma levels at the time of admission and the rapid peak of free plasma MPO levels after the onset of symptoms suggests that PMN activation is an early event in AMI and potentially precedes myocardial injury.
AB - Myeloperoxidase (MPO), a heme protein abundantly expressed and secreted by polymorphonuclear neutrophils (PMN), has emerged as a critical mediator in coronary atherosclerosis. Retrospective analyses have suggested that free plasma levels of MPO predict adverse outcome in patients with low troponin T (TnT) levels who subsequently experience myocardial injury. The aim of this study was to evaluate the time course of MPO plasma levels in the early stages of acute myocardial infarction (AMI). Of 155 consecutive patients hospitalized for acute coronary syndromes, 38 presenting within 2 h of the onset of symptoms and subsequently diagnosed for AMI were included in the study. Serial blood samples taken between 1 and 24 h after the onset of chest pain were analyzed for MPO, TnT, creatine kinase MB, myoglobin, and high sensitive C-reactive protein. Fifty patients with angiographically proven but stable coronary artery disease (CAD) served as controls. In contrast to all other investigated markers, MPO was markedly elevated within 2 h of symptom onset in patients with AMI. Heparin, which is known to increase MPO plasma levels in patients with stable CAD, had no effect on MPO plasma levels in AMI patients. High levels of MPO plasma levels at the time of admission and the rapid peak of free plasma MPO levels after the onset of symptoms suggests that PMN activation is an early event in AMI and potentially precedes myocardial injury.
KW - Aged
KW - Biomarkers/blood
KW - C-Reactive Protein/metabolism
KW - Chest Pain
KW - Coronary Artery Disease/blood
KW - Disease Progression
KW - Early Diagnosis
KW - Female
KW - Humans
KW - Male
KW - Middle Aged
KW - Myocardial Infarction/blood
KW - Myoglobin/blood
KW - Neutrophil Activation
KW - Neutrophils/immunology
KW - Pancreatic Elastase/blood
KW - Peroxidase/blood
KW - Prognosis
KW - Time Factors
KW - Troponin T/blood
U2 - 10.1016/j.freeradbiomed.2009.04.004
DO - 10.1016/j.freeradbiomed.2009.04.004
M3 - SCORING: Journal article
C2 - 19362143
VL - 47
SP - 79
EP - 83
JO - FREE RADICAL BIO MED
JF - FREE RADICAL BIO MED
SN - 0891-5849
IS - 1
ER -